Literature DB >> 35074570

Systemic sterile induced-co-expression of IL-12 and IL-18 drive IFN-γ-dependent activation of microglia and recruitment of MHC-II-expressing inflammatory monocytes into the brain.

Emilia A Gaviglio1, Javier M Peralta Ramos1, Daniela S Arroyo1, Claudio Bussi1, Pablo Iribarren1, Maria C Rodriguez-Galan2.   

Abstract

The development of neuroinflammation, as well as the progression of several neurodegenerative diseases, has been associated with the activation and mobilization of the peripheral immune system due to systemic inflammation. However, the mechanism by which this occurs remains unclear. Here, we addressed the effect of systemic sterile induced-co-expression of IL-12 and IL-18, in the establishment of a novel cytokine-mediated model of neuroinflammation. Following peripheral hydrodynamic shear of IL-12 plus IL-18 cDNAs in C57BL/6 mice, we induced systemic and persistent level of IL-12, which in turn promoted the elevation of circulating pro-inflammatory cytokines TNF-α and IFN-γ, accompanied with splenomegaly. Moreover, even though we identified an increased gene expression of both TNF-α and IFN-γ in the brain, we observed that only IFN-γ, but not TNF-α signaling through its type I receptor, was required to induce both the trafficking of leukocytes from the periphery toward the brain and upregulate MHC-II in microglia and inflammatory monocytes. Therefore, only TNF-α was shown to be dispensable, revealing an IFN-γ-dependent activation of microglia and recruitment of leukocytes, particularly of highly activated inflammatory monocytes. Taken together, our results argue for a systemic cytokine-mediated establishment and development of neuroinflammation, having identified IFN-γ as a potential target for immunomodulation.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytokine storm; Interferon-γ; Microglia; Monocytes; Sterile neuroinflammation

Mesh:

Substances:

Year:  2022        PMID: 35074570      PMCID: PMC8901210          DOI: 10.1016/j.intimp.2022.108546

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  51 in total

1.  Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial.

Authors:  E Antonio Chiocca; John S Yu; Rimas V Lukas; Isaac H Solomon; Keith L Ligon; Hiroshi Nakashima; Daniel A Triggs; David A Reardon; Patrick Wen; Brittany M Stopa; Ajay Naik; Jeremy Rudnick; Jethro L Hu; Priya Kumthekar; Bakhtiar Yamini; Jill Y Buck; Nathan Demars; John A Barrett; Arnold B Gelb; John Zhou; Francois Lebel; Laurence J N Cooper
Journal:  Sci Transl Med       Date:  2019-08-14       Impact factor: 17.956

Review 2.  Cytokine storm and sepsis disease pathogenesis.

Authors:  Benjamin G Chousterman; Filip K Swirski; Georg F Weber
Journal:  Semin Immunopathol       Date:  2017-05-29       Impact factor: 9.623

3.  The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18.

Authors:  Sushmita Jha; Siddharth Y Srivastava; W June Brickey; Heather Iocca; Arrel Toews; James P Morrison; Vivian S Chen; Denis Gris; Glenn K Matsushima; Jenny P-Y Ting
Journal:  J Neurosci       Date:  2010-11-24       Impact factor: 6.167

4.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.

Authors:  Daniel J Cua; Jonathan Sherlock; Yi Chen; Craig A Murphy; Barbara Joyce; Brian Seymour; Linda Lucian; Wayne To; Sylvia Kwan; Tatyana Churakova; Sandra Zurawski; Maria Wiekowski; Sergio A Lira; Daniel Gorman; Robert A Kastelein; Jonathon D Sedgwick
Journal:  Nature       Date:  2003-02-13       Impact factor: 49.962

5.  IFN-γ-dependent activation of the brain's choroid plexus for CNS immune surveillance and repair.

Authors:  Gilad Kunis; Kuti Baruch; Neta Rosenzweig; Alexander Kertser; Omer Miller; Tamara Berkutzki; Michal Schwartz
Journal:  Brain       Date:  2013-10-01       Impact factor: 13.501

6.  Glucose metabolism mediates disease tolerance in cerebral malaria.

Authors:  Andrew Wang; Sarah C Huen; Harding H Luan; Kelly Baker; Henry Rinder; Carmen J Booth; Ruslan Medzhitov
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-05       Impact factor: 11.205

7.  A 20-Year Journey from Axonal Injury to Neurodegenerative Diseases and the Prospect of Immunotherapy for Combating Alzheimer's Disease.

Authors:  Michal Schwartz; Javier M Peralta Ramos; Hila Ben-Yehuda
Journal:  J Immunol       Date:  2020-01-15       Impact factor: 5.422

Review 8.  Systemic inflammation and microglial activation: systematic review of animal experiments.

Authors:  Inge C M Hoogland; Carin Houbolt; David J van Westerloo; Willem A van Gool; Diederik van de Beek
Journal:  J Neuroinflammation       Date:  2015-06-06       Impact factor: 8.322

9.  Peripheral Inflammation Regulates CNS Immune Surveillance Through the Recruitment of Inflammatory Monocytes Upon Systemic α-Synuclein Administration.

Authors:  Javier María Peralta Ramos; Pablo Iribarren; Luc Bousset; Ronald Melki; Veerle Baekelandt; Anke Van der Perren
Journal:  Front Immunol       Date:  2019-01-29       Impact factor: 7.561

10.  Thymic expression of IL-4 and IL-15 after systemic inflammatory or infectious Th1 disease processes induce the acquisition of "innate" characteristics during CD8+ T cell development.

Authors:  Natalia S Baez; Fabio Cerbán; Constanza Savid-Frontera; Deborah L Hodge; Jimena Tosello; Eva Acosta-Rodriguez; Laura Almada; Adriana Gruppi; Maria Estefania Viano; Howard A Young; Maria Cecilia Rodriguez-Galan
Journal:  PLoS Pathog       Date:  2019-01-04       Impact factor: 6.823

View more
  1 in total

Review 1.  The Gut-Immune-Brain Axis: An Important Route for Neuropsychiatric Morbidity in Inflammatory Bowel Disease.

Authors:  Rebecca Katharina Masanetz; Jürgen Winkler; Beate Winner; Claudia Günther; Patrick Süß
Journal:  Int J Mol Sci       Date:  2022-09-21       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.